Textbook of Coronary Thrombosis and Thrombolysis
R. C. Becker
Springer Science & Business Media, Jan 31, 1998 - Medical - 679 pages
Teleologically, the hemostatic mechanism is among The of Coronary Thrombosis and the most fundamental yet complex physiologic pro- in essence, represents a heartfelt gift of cesses in humans. Early scientists and physicians were knowledge from a dedicated group of scientists and fascinated by the blood's ability to remain in a liquid clinicians, who collectively have set out on a mission state only to clot in response to vascular injury. The to minimize the societal impact of"hemostasis in the cellular and noncellular components of normal wrong place. " The book is divided into four distinct hemostasis took centuries to discover, and the intrica- sections: Part 1, Scientific Principles, lays down the cies of their delicate interactions are still being unrav- supporting foundation; Part 2, Clinical Application eled today. As is so often the case, an in-depth of Scientific Principles, places the knowledge base in appreciation of physiologic hemostasis, representing a a working perspective, directly applying science to basic life-sustaining sequence of events, paved the patient care; Part 3, New Dimensions, provides a way for understanding abnormal hemostasis or glimpse of tomorrow. Steering the field clear of se- pathologic thrombosis. Aristotle, Malpighi, and proclaimed victory and the dangers of complacency as Osier, representing but a few of the founding fathers we move into the 21st century, Part 4, Evolution of in the field, would undoubtedly be honored to see Thrombocardiology, focuses on laboratory standards, their observations form the template for lifesaving clinical trials, and drugs in development.
What people are saying - Write a review
We haven't found any reviews in the usual places.
acute coronary acute myocardial infarction adhesion agents alteplase angiographic angioplasty antibody anticoagulant antiplatelet antithrombotic aPTT aspirin assay atherosclerotic binding Biol Chem bleeding blood flow bolus cardiac Circulation Clin Invest clinical clot coagulation Coll Cardiol Collen complex coronary artery disease dose effect endothelial cells Engl enzyme estrogen factor VII factor Xa fibrin fibrinogen fibrinolytic function gene glycoprotein GPIIb/IIIa heart hemorrhage heparin hirudin human increased inhibition injury interaction intravenous ischemia ischemic left ventricular lesions levels markers MB-CK membrane mice molecular neutrophils occlusion patency patients with acute peptide plaque plasma plasmin plasminogen activator inhibitor platelet platelet activation platelet aggregation prehospital protein prothrombin PTCA randomized receptor recombinant reduced reocclusion reperfusion reteplase risk role smooth muscle cells streptokinase subforms t-PA Thromb Haemost thrombin thrombolytic therapy thrombosis thrombus TIMI tion tissue factor tissue plasminogen activator tissue-type plasminogen activator treatment trial troponin u-PA unstable angina urokinase vascular venous vessel vivo warfarin